Jilteza

Active Ingredient:: Metformin Hydrochloride
Origin:: EU

Jilteza (Metformin Hydrochloride)

Q: What is Jilteza used for?

Jilteza contains metformin hydrochloride and is prescribed primarily for the treatment of type 2 diabetes mellitus. It helps lower elevated blood glucose levels by improving the body’s response to insulin and reducing glucose production in the liver.

Q: How does Metformin work?

Metformin lowers blood sugar by inhibiting hepatic gluconeogenesis, enhancing peripheral glucose uptake, and modestly reducing intestinal glucose absorption. These actions collectively increase insulin sensitivity and decrease the amount of glucose released into the bloodstream.

Q: What is the usual dose of Jilteza?

The specific dose of Jilteza is individualized by a healthcare professional based on the patient’s clinical condition, renal function, and response to therapy. Prescribers determine the appropriate strength and dosing schedule for each patient.

Q: Is Jilteza safe during pregnancy or breastfeeding?

Safety data for metformin in pregnancy and lactation are limited. It is generally not recommended for routine use during pregnancy unless the potential benefit outweighs the risk, and breastfeeding mothers should consult their physician before continuing therapy.

Q: How do I order Jilteza from GNH India?

To place an order, submit an enquiry on the Jilteza product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Q: How does Jilteza compare with other antidiabetic drugs?

Compared with sulfonylureas or insulin, metformin (Jilteza) does not cause weight gain and has a lower risk of hypoglycemia when used alone. It is often used as first‑line therapy and can be combined with other agents for additional glucose‑lowering effect.

Q: How should Jilteza be stored and handled?

Jilteza should be stored at room temperature, below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children and do not use it after the expiration date.

Q: How is Jilteza administered?

Jilteza is taken orally, usually with meals to reduce gastrointestinal discomfort. The tablets (or other oral form) are swallowed whole with a glass of water. Patients should follow the dosing instructions provided by their prescriber.

Q: What are the most serious risks associated with Jilteza?

The most serious adverse effect is lactic acidosis, a rare but potentially fatal condition. Signs include rapid breathing, muscle pain, abdominal discomfort, and feeling unusually weak. Prompt medical attention is essential if these symptoms occur.

Q: Who should not use Jilteza?

Jilteza is contraindicated in patients with severe renal impairment (eGFR <30 mL/min/1.73 m²), acute or chronic metabolic acidosis, and those with known hypersensitivity to metformin. Caution is also advised for individuals with significant hepatic disease or heart failure.

Metformin, the active ingredient in Jilteza, is a biguanide presented as an unknown/unknown for oral use. It treats type 2 diabetes mellitus in adults by decreasing hepatic glucose production and increasing peripheral insulin sensitivity, thereby improving overall glycemic control.

GNH India supplies Jilteza as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring consistent quality and regulatory compliance across global markets. The company adheres to stringent manufacturing standards and provides reliable logistics support.

Manufacturer / TM Owner

Vita Longa Pc

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Metformin, the generic name for Jilteza, is used in the management of disorders related to glucose metabolism.

Type 2 diabetes mellitus: improves glycemic control and reduces HbA1c levels.
Prediabetes (impaired glucose tolerance): delays progression to overt diabetes.
Polycystic ovary syndrome: helps restore ovulation and improve insulin resistance.

How It Works

Metformin acts primarily by inhibiting mitochondrial respiratory‑chain complex I, which reduces hepatic gluconeogenesis. The resulting decrease in hepatic glucose output, together with enhanced peripheral glucose uptake in muscle and adipose tissue, improves insulin sensitivity. It also modestly lowers intestinal absorption of glucose and may influence gut microbiota, contributing to its overall antihyperglycemic effect.

Side Effects

Metformin may cause a range of adverse reactions, most of which are related to the gastrointestinal system or metabolic disturbances.

Common Side Effects

Nausea: mild to moderate stomach discomfort.
Diarrhea: frequent loose stools.
Abdominal discomfort: cramping or bloating.
Metallic taste: transient alteration in taste perception.

Serious or Rare Side Effects

Lactic acidosis: rare but potentially fatal buildup of lactate.
Severe skin reactions (Stevens‑Johnson syndrome): life‑threatening rash.
Hepatic dysfunction: signs of liver injury.
Vitamin B12 deficiency: long‑term use may reduce B12 levels.

Precautions & Warnings

Before initiating therapy, several safety considerations should be addressed.

Renal function assessment: evaluate creatinine clearance prior to use.
Hepatic function monitoring: check liver enzymes periodically.
Risk of lactic acidosis: avoid in patients with severe heart failure or hypoxia.
Use caution in elderly: start with lower doses and monitor tolerance.
Contraindicated in severe renal impairment: do not use if eGFR <30 mL/min/1.73 m².
Store at room temperature: keep in original container, protect from moisture.

Avoid Interactions

Metformin interacts with several medicines; some require avoidance while others need careful monitoring.

Major Interactions (Avoid)

Iodinated contrast agents: may precipitate acute renal failure and increase lactic acidosis risk.
Cimetidine: can raise metformin plasma concentrations.
Alcohol: excessive intake heightens lactic acidosis potential.

Moderate Interactions (Monitor Closely)

Beta‑blockers: may mask hypoglycemia symptoms.
ACE inhibitors or ARBs: can affect renal function, requiring dose adjustment.
Thiazide diuretics: may increase risk of hypoglycemia.
NSAIDs: can reduce renal clearance of metformin.

Frequently Asked Questions

Jilteza contains metformin hydrochloride and is prescribed primarily for the treatment of type 2 diabetes mellitus. It helps lower elevated blood glucose levels by improving the body’s response to insulin and reducing glucose production in the liver.

Metformin lowers blood sugar by inhibiting hepatic gluconeogenesis, enhancing peripheral glucose uptake, and modestly reducing intestinal glucose absorption. These actions collectively increase insulin sensitivity and decrease the amount of glucose released into the bloodstream.

The specific dose of Jilteza is individualized by a healthcare professional based on the patient’s clinical condition, renal function, and response to therapy. Prescribers determine the appropriate strength and dosing schedule for each patient.

Safety data for metformin in pregnancy and lactation are limited. It is generally not recommended for routine use during pregnancy unless the potential benefit outweighs the risk, and breastfeeding mothers should consult their physician before continuing therapy.

To place an order, submit an enquiry on the Jilteza product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with sulfonylureas or insulin, metformin (Jilteza) does not cause weight gain and has a lower risk of hypoglycemia when used alone. It is often used as first‑line therapy and can be combined with other agents for additional glucose‑lowering effect.

Jilteza should be stored at room temperature, below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children and do not use it after the expiration date.

Jilteza is taken orally, usually with meals to reduce gastrointestinal discomfort. The tablets (or other oral form) are swallowed whole with a glass of water. Patients should follow the dosing instructions provided by their prescriber.

The most serious adverse effect is lactic acidosis, a rare but potentially fatal condition. Signs include rapid breathing, muscle pain, abdominal discomfort, and feeling unusually weak. Prompt medical attention is essential if these symptoms occur.

Jilteza is contraindicated in patients with severe renal impairment (eGFR <30 mL/min/1.73 m²), acute or chronic metabolic acidosis, and those with known hypersensitivity to metformin. Caution is also advised for individuals with significant hepatic disease or heart failure.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 15 Aug 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.